We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+7.06%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$25.9B
AUM Growth
+$1.75B
Cap. Flow
+$434M
Cap. Flow %
1.67%
Top 10 Hldgs %
23.48%
Holding
1,080
New
134
Increased
325
Reduced
445
Closed
139

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$189M
2
INTC icon
Intel
INTC
+$180M
3
APH icon
Amphenol
APH
+$132M
4
INTU icon
Intuit
INTU
+$106M
5
LUV icon
Southwest Airlines
LUV
+$86.2M

Top Sells

Rank Stock Value
1
FTNT icon
Fortinet
FTNT
+$221M
2
CEG icon
Constellation Energy
CEG
+$181M
3
UBER icon
Uber
UBER
+$169M
4
MA icon
Mastercard
MA
+$140M
5
EXC icon
Exelon
EXC
+$108M

Sector Composition

Rank Sector Weight
1 Technology 30.39%
2 Financials 14.25%
3 Consumer Discretionary 12.97%
4 Industrials 12.61%
5 Healthcare 10.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCB icon
526
Metropolitan Bank Holding Corp
MCB
$1.14B
$2.96M 0.01%
56,278
-17,996
-24% -$889K
SGC icon
527
Superior Group of Companies
SGC
$200M
$2.96M 0.01%
190,878
+89,096
+88% +$1.45M
REYN icon
528
Reynolds Consumer Products
REYN
$5.41B
$2.94M 0.01%
94,446
-621
-0.7% -$18.4K
KLAC icon
529
KLA
KLAC
$230B
$2.9M 0.01%
37,510
+34,250
+1,051% +$2.69M
LSEA
530
DELISTED
Landsea Homes
LSEA
$2.9M 0.01%
234,878
-37,295
-14% -$425K
ATNI icon
531
ATN International
ATNI
$363M
$2.88M 0.01%
89,140
+23,099
+35% +$608K
WGS icon
532
GeneDx Holdings
WGS
$1.87B
$2.88M 0.01%
67,776
-134,287
-66% -$4.54M
RIGL icon
533
Rigel Pharmaceuticals
RIGL
$705M
$2.87M 0.01%
177,340
-60,913
-26% -$716K
SFIX
534
Stitch Fix
SFIX
$558M
$2.86M 0.01%
+1,014,922
New +$3.95M
STRO icon
535
Sutro Biopharma
STRO
$383M
$2.84M 0.01%
82,175
-22,844
-22% -$895K
INGN icon
536
Inogen
INGN
$174M
$2.82M 0.01%
290,868
-19,488
-6% -$204K
ZION icon
537
Zions Bancorporation
ZION
$10.2B
$2.8M 0.01%
59,368
+2,523
+4% +$119K
BCRX icon
538
BioCryst Pharmaceuticals
BCRX
$2.43B
$2.79M 0.01%
367,514
-372,085
-50% -$2.83M
CDXS icon
539
Codexis
CDXS
$159M
$2.76M 0.01%
895,695
-114,194
-11% -$353K
BLND icon
540
Blend Labs
BLND
$433M
$2.74M 0.01%
730,294
+1,253
+0.2% +$4.15K
VC icon
541
Visteon
VC
$2.87B
$2.71M 0.01%
28,500
-26,462
-48% -$2.69M
LGTY
542
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$2.71M 0.01%
242,443
-80,454
-25% -$836K
LNC icon
543
Lincoln National
LNC
$8.11B
$2.7M 0.01%
85,768
-14,159
-14% -$441K
CSV icon
544
Carriage Services
CSV
$647M
$2.7M 0.01%
82,238
+4,850
+6% +$150K
TEX icon
545
Terex
TEX
$7.44B
$2.7M 0.01%
50,963
-129,431
-72% -$7.15M
AKBA icon
546
Akebia Therapeutics
AKBA
$335M
$2.69M 0.01%
2,034,169
-60,564
-3% -$80.9K
CR icon
547
Crane Co
CR
$12.2B
$2.68M 0.01%
+16,956
New +$2.55M
UHAL icon
548
U-Haul Holding Co
UHAL
$14.2B
$2.68M 0.01%
34,541
-73,021
-68% -$4.99M
AMTM
549
Amentum Holdings
AMTM
$5.41B
$2.66M 0.01%
+82,399
New +$2.35M
TRMK icon
550
Trustmark
TRMK
$2.76B
$2.63M 0.01%
82,526
-153
-0.2% -$4.92K

Similar funds

Jacobs Levy Equity Management's Q3 2024 Portfolio in Review

As of Q3 2024, Jacobs Levy Equity Management held 1,080 positions worth $25.9B, up 7.2% from $24.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Jacobs Levy Equity Management's Q3 2024 filing shows 134 new, 325 increased, 445 reduced and 139 closed positions. Its largest new stake was Lam Research: 962,880 shares worth $78.6M. The largest sale was Fortinet, an estimated $221M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Jacobs Levy Equity Management's largest Q3 2024 buy was Lam Research: 962,880 shares worth $78.6M.
  • Jacobs Levy Equity Management added most to Edwards Lifesciences in Q3 2024, an estimated $189M increase.
  • Jacobs Levy Equity Management's biggest Q3 2024 reduction was Fortinet, cutting an estimated $221M.
  • Jacobs Levy Equity Management fully exited Smartsheet Inc. in Q3 2024, selling an estimated $81.1M.
  • Jacobs Levy Equity Management's ten largest holdings make up 23% of its $25.9B portfolio in Q3 2024.
  • Jacobs Levy Equity Management opened 134 new positions and closed 139 in Q3 2024.
  • Jacobs Levy Equity Management's portfolio value rose 7.2% quarter-over-quarter to $25.9B.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2024, filed 14 Nov 2024.